Yang X. et al. (2018) demonstrated that PDIA3P was highly expressed in multiple myeloma, was correlated with poor prognosis of patients with multiple myeloma, and induced growth and drug resistance of multiple myeloma. Here, PDIA3P1 is linked to plasma cell myeloma.